Trial · NCT02180711
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | P1: RR Acalabrutinib 100 mg BID | 12 | |
| Overall Study | STARTED | P1: RR Acalabrutinib 100 mg BID + Rituximab | 13 | |
| Overall Study | STARTED | P1: RR Acalabrutinib 200 mg QD | 2 | |
| Overall Study | STARTED | P1: TN Acalabrutinib 100 mg BID + Rituximab | 13 | |
| Overall Study | STARTED | P2: Acalabrutinib | 43 | |
| Overall Study | STARTED | P2: Acalabrutinib + Rituximab | 1 | |
| Overall Study | STARTED | P3: Acalabrutinib + Rituximab + Lenalidomide 15 mg | 8 | |
| Overall Study | STARTED | P3: Acalabrutinib + Rituximab + Lenalidomide 20 mg | 21 | |
| Overall Study | COMPLETED | P1: RR Acalabrutinib 100 mg BID | 0 | |
| Overall Study | COMPLETED | P1: RR Acalabrutinib 100 mg BID + Rituximab | 0 | |
| Overall Study | COMPLETED | P1: RR Acalabrutinib 200 mg QD | 0 | |
| Overall Study | COMPLETED | P1: TN Acalabrutinib 100 mg BID + Rituximab | 0 | |
| Overall Study | COMPLETED | P2: Acalabrutinib | 0 | |
| Overall Study | COMPLETED | P2: Acalabrutinib + Rituximab | 0 | |
| Overall Study | COMPLETED | P3: Acalabrutinib + Rituximab + Lenalidomide 15 mg | 0 | |
| Overall Study | COMPLETED | P3: Acalabrutinib + Rituximab + Lenalidomide 20 mg | 0 | |
| Overall Study | NOT COMPLETED | P1: RR Acalabrutinib 100 mg BID | 12 | |
| Overall Study | NOT COMPLETED | P1: RR Acalabrutinib 100 mg BID + Rituximab | 13 | |
| Overall Study | NOT COMPLETED | P1: RR Acalabrutinib 200 mg QD | 2 | |
| Overall Study | NOT COMPLETED | P1: TN Acalabrutinib 100 mg BID + Rituximab | 13 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02180711/flow